2 exciting ETFs named as buys by experts

Here are two ETFs that could be buys…

| More on:
A young woman sits with her hand to her chin staring off to the side thinking about her investments.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're wanting to buy some exchange traded funds (ETFs), then you certainly have a lot of options.

But which ones could be buys? Two that have been tipped as buys by analysts are listed below. Here's what they are saying about them:

ETFS Battery Tech & Lithium ETF (ASX: ACDC)

If you're wanting to get some exposure to the decarbonisation megatrend, then the ETFS Battery Tech & Lithium ETF could be one way to do it.

This popular ETF allows investors to buy a slice of companies involved in battery technology, electric vehicles, and lithium mining. This includes BYD, Mineral Resources Limited (ASX: MIN), Pilbara Minerals Ltd (ASX: PLS), Nissan, and Renault.

Jessica Amir from Saxo Markets is positive on the ETF. Especially for investors that aren't keen on stock picking in the lithium sector. She commented:

If stock picking is not for you, and if you believe, like we do, that the electric vehicle industry and the critical minerals/ commodities will continue to see rising demand, and policy support, and also benefit from the world striving to be carbon neutral by 2050, then you could invest or trade in Global X Lithium & Battery Tech ETF (LIT) or ETFS Battery Tech & Lithium ETF (ACDC) that invests in about 30 of the biggest EV and battery technology companies in the world.

ETFS S&P Biotech ETF (ASX: CURE)

Another ETF that has been tipped as a buy is the ETFS S&P Biotech ETF. As its name implies, this ETF gives investors access to U.S. healthcare biotechnology companies.

The fund manager notes that these companies are engaged in the research, development and manufacturing of products based on genetic analysis and genetic engineering. This includes the development of immunotherapy treatments and vaccines to treat human diseases.

Among its largest holdings are ChemoCentryx, Global Blood Therapeutics, and Twist Bioscience.

Felicity Thomas from Shaw & Partners is a fan of the ETF. She recently told Livewire:

I like to buy ETFs for the long term. We have an ageing population, and what's the most important thing in the world? Your health. Biotech, healthcare, and life sciences, that's where you want to be invested over the next couple of decades.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ETFs

The letters ETF with a man pointing at it.
ETFs

Invest $10,000 into these ASX ETFs next week

These ETFs provide investors with access to some high quality companeis.

Read more »

Businessman at the beach building a wall around his sandcastle, signifying protecting his business.
ETFs

Is the Vaneck Morningstar Wide Moat ETF (MOAT) a good long-term investment?

Is this ASX ETF a top pick to hold for years to come?

Read more »

ETF with different images around it on top of a tablet.
ETFs

4 quality ASX ETFs to buy after the market sell-off

Here's why these funds could be buys after recent market volatility.

Read more »

Hand holding Australian dollar (AUD) bills, symbolising ex dividend day. Passive income.
ETFs

Own Vanguard Australian Shares Index ETF (VAS) units? It's payday for you!

Find out what distribution VAS ETF is sending to bank accounts today.

Read more »

A young office worker is surrounded by peers who are clapping and congratulating her.
ETFs

3 reasons I think this fantastic ASX ETF is a top buy

Quality is just one factor that makes this ETF is a great pick, in my opinion.

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
ETFs

4 ASX ETFs for growth investors to buy this month

These ETFs give investors easy access to large group of growth shares.

Read more »

A young woman with glasses holds a pencil to her lips as she is surrounded by the reflection of data as though she is being photographed through a glass screen project with digital data.
ETFs

This compelling ASX ETF may be a better way to invest in Aussie stocks than Vanguard Australian Shares Index ETF (VAS)

This ASX ETF could be an even more effective investment than Vanguard’s.

Read more »

Man smiling at a laptop because of a rising share price.
ETFs

How does direct indexing compare to buying ASX ETFs

Do you like index investing, but want more say in which stocks you pick?

Read more »